AF151
Product Specifications
Target
Apoptosis, PROTACs, Bcl-2 Family, Others
Related Pathways
PROTAC, Apoptosis, Others
Bioactivity
AF151 is a METTL3 PROTAC degrader with a DC50 of 0.43 μM in MOLM-13 cells. It inhibits cell growth by significantly degrading METTL3 protein and reducing m6A levels. AF151 induces apoptosis and decreases Bcl-2 protein levels. This compound is applicable in research related to cancers such as acute myeloid leukemia (AML) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
CSB-YP012023HU-01 20 µg
Recombinant Human A-type voltage-gated potassium channel KCND2 (KCND2), partial
Sign In for Pricing
View Details CSB-YP012023HU-02 100 µg
Recombinant Human A-type voltage-gated potassium channel KCND2 (KCND2), partial
Sign In for Pricing
View Details CSB-YP012023HU-03 1 mg
Recombinant Human A-type voltage-gated potassium channel KCND2 (KCND2), partial
Sign In for Pricing
View Details